NCT03830411 2021-11-08
A Study of Sintilimab Compared With Docetaxel or Pemetrexed as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer After Failure With Platinum-Containing Chemotherapy
China Three Gorges University, Yichang, China
Phase 2 Unknown